{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:10:24Z","timestamp":1790975424738,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005774","name":"Universitat de Barcelona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijgc.2025.102729","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:21:14Z","timestamp":1773937274000},"page":"102729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of topical treatments for high-risk human papillomavirus in preventing CIN II+ lesions: a systematic review"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0093-0438","authenticated-orcid":false,"given":"Rene","family":"Pareja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1165-0661","authenticated-orcid":false,"given":"N\u00faria","family":"Agust\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0348-4317","authenticated-orcid":false,"given":"Santiago","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4240-2227","authenticated-orcid":false,"given":"Nathalia","family":"Mora-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1077-5796","authenticated-orcid":false,"given":"Emmanuel","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0589-2696","authenticated-orcid":false,"given":"Andre\u00edna","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7697-4915","authenticated-orcid":false,"given":"Beatriz","family":"Aristiz\u00e1bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4716-4216","authenticated-orcid":false,"given":"Fernando","family":"Heredia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8960-8017","authenticated-orcid":false,"given":"Melissa Lopez","family":"Varon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6375-0736","authenticated-orcid":false,"given":"Mila","family":"Pontremoli Salcedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate J.","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warner","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Alejandro","family":"Rauh-Hain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9395-0627","authenticated-orcid":false,"given":"David","family":"Viveros-Carre\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijgc.2025.102729_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102729_bib2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol."},{"issue":"5","key":"10.1016\/j.ijgc.2025.102729_bib3","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"zur Hausen","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijgc.2025.102729_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-67452-6_1","article-title":"Human papillomavirus-associated cancers","volume":"1313","author":"Alhamlan","year":"2021","journal-title":"Adv Exp Med Biol."},{"issue":"19","key":"10.1016\/j.ijgc.2025.102729_bib5","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMcp2108502","article-title":"Human papillomavirus vaccination","volume":"388","author":"Markowitz","year":"2023","journal-title":"N Engl J Med"},{"issue":"suppl 6","key":"10.1016\/j.ijgc.2025.102729_bib6","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1016\/j.vaccine.2013.10.002","article-title":"Comprehensive control of human papillomavirus infections and related diseases","volume":"31","author":"Bosch","year":"2013","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.ijgc.2025.102729_bib7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ijgc.2025.102729_bib8","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/jog.15726","article-title":"The significance of nonsurgical therapies for cervical infection of high-risk human papilloma virus: a systematic review and meta-analysis","volume":"49","author":"Zhuang","year":"2023","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102729_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.ijgc.2025.102729_bib10","article-title":"Cervical cancer screening guidelines and screening practices in 11 countries: a systematic literature review","volume":"28","author":"Wang","year":"2022","journal-title":"Prev Med Rep"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102729_bib11","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00404-020-05816-8","article-title":"Efficacy and safety of an adsorbent and anti-oxidative vaginal gel on CIN1 and 2, on high-risk HPV, and on p16\/Ki-67: a randomized controlled trial","volume":"303","author":"Major","year":"2021","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ijgc.2025.102729_bib12","article-title":"An adsorptive and antioxidant vaginal gel clears high-risk HPV- and p16\/Ki-67-associated abnormal cytological cervical findings: a post-hoc subgroup analysis of a prospective randomized controlled trial on CIN2 and p16 positive CIN1","volume":"8","author":"Major","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"10.1016\/j.ijgc.2025.102729_bib13","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.3390\/jcm12124142","article-title":"Successful preventive treatment of oncogenic transforming HPV infections in low-grade cytology (ASC-US\/LSIL) patients with an adsorptive and antioxidant vaginal gel","volume":"12","author":"Major","year":"2023","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.ijgc.2025.102729_bib14","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3390\/jpm12101559","article-title":"Efficacy of a Coriolusversicolor-based vaginal gel in human papillomavirus-positive women older than 40 years: a sub-analysis of PALOMA study","volume":"12","author":"Gil-Antu\u00f1ano","year":"2022","journal-title":"J Pers Med"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102729_bib15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/LGT.0000000000000596","article-title":"Efficacy of a Coriolus versicolor-based vaginal gel in women with human papillomavirus-dependent cervical lesions: the PALOMA study","volume":"25","author":"Serrano","year":"2021","journal-title":"J Low Genit Tract Dis"},{"issue":"11","key":"10.1016\/j.ijgc.2025.102729_bib16","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1471-0528.1986.tb08634.x","article-title":"The effect of interferon on human papillomaviruses associated with cervical intraepithelial neoplasia","volume":"93","author":"Byrne","year":"1986","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102729_bib17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0090-8258(90)90141-7","article-title":"Topical treatment with human leukocyte interferon of HPV 16 infections associated with cervical and vaginal intraepithelial neoplasias","volume":"36","author":"Yliskoski","year":"1990","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2025.102729_bib18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00008469-200310000-00007","article-title":"Protective effects of green tea extracts (Polyphenon E and EGCG) on human cervical lesions","volume":"12","author":"Ahn","year":"2003","journal-title":"Eur J Cancer Prev"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102729_bib19","first-page":"79","article-title":"Efficacy in treatment of cervical HRHPV infection by combination of beta interferon, and herbal therapy in woman with different cervical lesions","volume":"6","author":"Iljazovi\u0107","year":"2006","journal-title":"Bosn J Basic Med Sci."},{"key":"10.1016\/j.ijgc.2025.102729_bib20","article-title":"Impact of antiviral AV2 in the topical treatment of HPV-associated lesions of the cervix: results of a phase III randomized placebo-controlled trial","volume":"15","author":"Baleka Mutombo","year":"2019","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.ijgc.2025.102729_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102038","article-title":"Efficacy and safety of a self-applied carrageenan-based gel to prevent human papillomavirus infection in sexually active young women (CATCH study): an exploratory phase IIB randomised, placebo-controlled trial","volume":"60","author":"Laurie","year":"2023","journal-title":"EClinicalmedicine"},{"issue":"12","key":"10.1016\/j.ijgc.2025.102729_bib22","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00432-009-0617-1","article-title":"Elimination of high-risk human papillomavirus type HPV16 infection by \u2018praneem\u2019 polyherbal tablet in women with early cervical intraepithelial lesions","volume":"135","author":"Shukla","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102729_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.micinf.2015.10.004","article-title":"A randomized open-label clinical trial of an anti-HPV biological dressing (JB01-BD) administered intravaginally to treat high-risk HPV infection","volume":"18","author":"Guo","year":"2016","journal-title":"Microbes Infect"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102729_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.31083\/j.ejgo.2021.02.5509","article-title":"Clinical observation and mechanism of the elimination of HPV16\/18\/58 subtype infection and the reversal of grade I cervical intraepithelial neoplasia in Han Chinese women treated with modified Ermiao granules","volume":"42","author":"Xu","year":"2021","journal-title":"Eur J Gynaecol Oncol"},{"issue":"10","key":"10.1016\/j.ijgc.2025.102729_bib25","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1002\/ijc.32344","article-title":"REBACIN\u00ae as a noninvasive clinical intervention for high-risk human papillomavirus persistent infection","volume":"145","author":"Yang","year":"2019","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102729_bib26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/(SICI)1098-0997(1999)7:4<186::AID-IDOG4>3.0.CO;2-Z","article-title":"A randomized, double-blind, placebo-controlled trial of 5-fluorouracil for the treatment of cervicovaginal human papillomavirus","volume":"7","author":"Holmes","year":"1999","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102729_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12905-019-0798-y","article-title":"The influence of probiotics on genital high-risk human papilloma virus clearance and quality of cervical smear: a randomized placebo-controlled trial","volume":"19","author":"Ou","year":"2019","journal-title":"BMC Womens Health"},{"issue":"5","key":"10.1016\/j.ijgc.2025.102729_bib28","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3390\/medicina58050646","article-title":"Echinacea angustifolia and Echinacea purpurea supplementation combined with vaginal hyaluronic acid to boost the remission of cervical low-grade squamous intraepithelial lesions (L-SILs): a randomized controlled trial","volume":"58","author":"Riemma","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.ijgc.2025.102729_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1047222","article-title":"REBACIN\u00ae inhibits E6\/E7 oncogenes in clearance of human papillomavirus infection","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijgc.2025.102729_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479","article-title":"Human papillomavirus and cervical cancer--burden and assessment of causality","volume":"31","author":"Bosch","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102729_bib31","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1006\/gyno.2001.6323","article-title":"Biopsy correlates of abnormal cervical cytology classified using the Bethesda system","volume":"82","author":"Massad","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2025.102729_bib32","series-title":"WHO Guideline for Screening and Treatment of Cervical Pre-cancer Lesions for Cervical Cancer Prevention","year":"2021"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102729_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/LGT.0000000000000604","article-title":"The natural history of cervical intraepithelial neoplasia grades 1, 2, and 3: a systematic review and meta-analysis","volume":"25","author":"Loopik","year":"2021","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.ijgc.2025.102729_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100293","article-title":"A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs","volume":"22","author":"Demarco","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ijgc.2025.102729_bib35","article-title":"Topical therapies for the treatment of cervical intraepithelial neoplasia (CIN) 2-3: a narrative review","volume":"33","author":"Desravines","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.ijgc.2025.102729_bib36","article-title":"Effect of different interventions on the treatment of high-risk human papillomavirus infection: a systematic review and network meta-analysis","volume":"11","author":"Wang","year":"2024","journal-title":"Front Med (Lausanne)"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25018493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25018493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:31:21Z","timestamp":1776346281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X25018493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1048891X25018493"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.102729","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of topical treatments for high-risk human papillomavirus in preventing CIN II+ lesions: a systematic review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.102729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102729"}}